| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 1.21e-05 | 30 | 30 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 1.21e-05 | 30 | 30 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 5.95e-05 | 1244 | 30 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.03e-05 | 1271 | 30 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 7.80e-05 | 9 | 30 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 9.75e-05 | 10 | 30 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 9.88e-05 | 60 | 30 | 3 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 1.04e-04 | 61 | 30 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.58e-04 | 1412 | 30 | 9 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.03e-04 | 1459 | 30 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 2.93e-04 | 17 | 30 | 2 | GO:0070411 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat modifying activity | 5.41e-04 | 23 | 30 | 2 | GO:0140994 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.84e-03 | 600 | 30 | 5 | GO:0004672 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.03e-03 | 363 | 30 | 4 | GO:0106310 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 3.79e-03 | 709 | 30 | 5 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 4.25e-03 | 446 | 30 | 4 | GO:0004674 | |
| GeneOntologyMolecularFunction | kinase activity | 5.21e-03 | 764 | 30 | 5 | GO:0016301 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 6.57e-03 | 81 | 30 | 2 | GO:0016811 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 2.39e-06 | 19 | 29 | 3 | GO:0055012 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 5.30e-06 | 327 | 29 | 6 | GO:0048738 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 7.69e-06 | 349 | 29 | 6 | GO:0014706 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 1.47e-05 | 107 | 29 | 4 | GO:0001657 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 1.64e-05 | 110 | 29 | 4 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 1.64e-05 | 110 | 29 | 4 | GO:0072163 | |
| GeneOntologyBiologicalProcess | mesonephros development | 1.82e-05 | 113 | 29 | 4 | GO:0001823 | |
| GeneOntologyBiologicalProcess | central nervous system development | 2.52e-05 | 1197 | 29 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | organ growth | 2.64e-05 | 256 | 29 | 5 | GO:0035265 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 2.85e-05 | 6 | 29 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | heart development | 6.72e-05 | 757 | 29 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 7.47e-05 | 162 | 29 | 4 | GO:0072073 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.07e-04 | 558 | 29 | 6 | GO:0060537 | |
| GeneOntologyBiologicalProcess | brain development | 1.48e-04 | 859 | 29 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 1.98e-04 | 81 | 29 | 3 | GO:0061035 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell proliferation | 2.05e-04 | 82 | 29 | 3 | GO:0060038 | |
| GeneOntologyBiologicalProcess | head development | 2.25e-04 | 919 | 29 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | gliogenesis | 3.19e-04 | 435 | 29 | 5 | GO:0042063 | |
| GeneOntologyBiologicalProcess | cartilage development | 3.54e-04 | 243 | 29 | 4 | GO:0051216 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 3.60e-04 | 244 | 29 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of glial cell differentiation | 4.14e-04 | 104 | 29 | 3 | GO:0045685 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 4.25e-04 | 105 | 29 | 3 | GO:0048708 | |
| GeneOntologyBiologicalProcess | negative regulation of astrocyte differentiation | 4.33e-04 | 22 | 29 | 2 | GO:0048712 | |
| GeneOntologyBiologicalProcess | bone development | 4.84e-04 | 264 | 29 | 4 | GO:0060348 | |
| GeneOntologyBiologicalProcess | striated muscle cell proliferation | 4.87e-04 | 110 | 29 | 3 | GO:0014855 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 4.99e-04 | 1048 | 29 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | forebrain development | 5.44e-04 | 489 | 29 | 5 | GO:0030900 | |
| GeneOntologyBiologicalProcess | circulatory system development | 6.37e-04 | 1442 | 29 | 8 | GO:0072359 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 7.57e-04 | 29 | 29 | 2 | GO:0003417 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 7.90e-04 | 531 | 29 | 5 | GO:0042692 | |
| GeneOntologyBiologicalProcess | cerebral cortex radial glia-guided migration | 8.10e-04 | 30 | 29 | 2 | GO:0021801 | |
| GeneOntologyBiologicalProcess | telencephalon glial cell migration | 8.10e-04 | 30 | 29 | 2 | GO:0022030 | |
| GeneOntologyBiologicalProcess | response to alcohol | 9.05e-04 | 312 | 29 | 4 | GO:0097305 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 9.43e-04 | 138 | 29 | 3 | GO:0055017 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 1.01e-03 | 321 | 29 | 4 | GO:0010001 | |
| GeneOntologyBiologicalProcess | telencephalon development | 1.14e-03 | 332 | 29 | 4 | GO:0021537 | |
| GeneOntologyBiologicalProcess | heart growth | 1.15e-03 | 148 | 29 | 3 | GO:0060419 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 1.17e-03 | 36 | 29 | 2 | GO:0061037 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.22e-03 | 338 | 29 | 4 | GO:0045165 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.28e-03 | 343 | 29 | 4 | GO:0061448 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 1.30e-03 | 38 | 29 | 2 | GO:0048384 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 1.37e-03 | 39 | 29 | 2 | GO:0003416 | |
| GeneOntologyBiologicalProcess | negative regulation of glial cell differentiation | 1.37e-03 | 39 | 29 | 2 | GO:0045686 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 1.41e-03 | 605 | 29 | 5 | GO:0071407 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 1.44e-03 | 40 | 29 | 2 | GO:0003161 | |
| GeneOntologyBiologicalProcess | response to ethanol | 1.47e-03 | 161 | 29 | 3 | GO:0045471 | |
| GeneOntologyBiologicalProcess | columnar/cuboidal epithelial cell differentiation | 1.55e-03 | 164 | 29 | 3 | GO:0002065 | |
| GeneOntologyBiologicalProcess | cerebral cortex radially oriented cell migration | 1.59e-03 | 42 | 29 | 2 | GO:0021799 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell development | 1.66e-03 | 43 | 29 | 2 | GO:0002068 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte differentiation | 1.66e-03 | 43 | 29 | 2 | GO:0048710 | |
| GeneOntologyBiologicalProcess | kidney development | 1.73e-03 | 372 | 29 | 4 | GO:0001822 | |
| GeneOntologyBiologicalProcess | bone growth | 1.82e-03 | 45 | 29 | 2 | GO:0098868 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 1.83e-03 | 174 | 29 | 3 | GO:1904064 | |
| GeneOntologyBiologicalProcess | regulation of hematopoietic progenitor cell differentiation | 1.90e-03 | 46 | 29 | 2 | GO:1901532 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 1.93e-03 | 177 | 29 | 3 | GO:0055007 | |
| GeneOntologyBiologicalProcess | renal system development | 1.98e-03 | 386 | 29 | 4 | GO:0072001 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.98e-03 | 47 | 29 | 2 | GO:0060351 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 2.07e-03 | 48 | 29 | 2 | GO:0051281 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 2.40e-03 | 407 | 29 | 4 | GO:0045787 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 2.43e-03 | 192 | 29 | 3 | GO:0034767 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 2.61e-03 | 1390 | 29 | 7 | GO:0045944 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.61e-03 | 197 | 29 | 3 | GO:0030509 | |
| GeneOntologyBiologicalProcess | cerebral cortex cell migration | 2.80e-03 | 56 | 29 | 2 | GO:0021795 | |
| GeneOntologyBiologicalProcess | response to amine | 3.00e-03 | 58 | 29 | 2 | GO:0014075 | |
| GeneOntologyCellularComponent | CKM complex | 1.99e-05 | 5 | 30 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 5.55e-05 | 8 | 30 | 2 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 8.90e-05 | 10 | 30 | 2 | GO:0071141 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 9.07e-05 | 61 | 30 | 3 | GO:0000307 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 3.00e-04 | 18 | 30 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.45e-03 | 157 | 30 | 3 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.83e-03 | 170 | 30 | 3 | GO:1902911 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 6.82e-03 | 272 | 30 | 3 | GO:0090575 | |
| Domain | GSDH | 7.48e-06 | 3 | 30 | 2 | PF07995 | |
| Domain | Glc/Sorbosone_DH | 7.48e-06 | 3 | 30 | 2 | IPR012938 | |
| Domain | Retinoic_acid_rcpt | 1.49e-05 | 4 | 30 | 2 | IPR003078 | |
| Domain | zf-C4 | 5.42e-05 | 46 | 30 | 3 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.42e-05 | 46 | 30 | 3 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 5.42e-05 | 46 | 30 | 3 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 5.42e-05 | 46 | 30 | 3 | IPR001723 | |
| Domain | ZnF_C4 | 5.42e-05 | 46 | 30 | 3 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.42e-05 | 46 | 30 | 3 | PS51030 | |
| Domain | - | 5.78e-05 | 47 | 30 | 3 | 1.10.565.10 | |
| Domain | HOLI | 6.16e-05 | 48 | 30 | 3 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 6.16e-05 | 48 | 30 | 3 | IPR000536 | |
| Domain | Hormone_recep | 6.16e-05 | 48 | 30 | 3 | PF00104 | |
| Domain | Dwarfin | 6.94e-05 | 8 | 30 | 2 | IPR013790 | |
| Domain | DWB | 6.94e-05 | 8 | 30 | 2 | SM00524 | |
| Domain | - | 6.94e-05 | 8 | 30 | 2 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 6.94e-05 | 8 | 30 | 2 | IPR013019 | |
| Domain | MH2 | 6.94e-05 | 8 | 30 | 2 | PS51076 | |
| Domain | MH1 | 6.94e-05 | 8 | 30 | 2 | PS51075 | |
| Domain | Folate_rcpt-like | 6.94e-05 | 8 | 30 | 2 | IPR018143 | |
| Domain | MH2 | 6.94e-05 | 8 | 30 | 2 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 6.94e-05 | 8 | 30 | 2 | IPR001132 | |
| Domain | Folate_rec | 6.94e-05 | 8 | 30 | 2 | PF03024 | |
| Domain | - | 1.03e-04 | 57 | 30 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.09e-04 | 58 | 30 | 3 | IPR013088 | |
| Domain | MAD_homology1_Dwarfin-type | 1.63e-04 | 12 | 30 | 2 | IPR003619 | |
| Domain | DWA | 1.63e-04 | 12 | 30 | 2 | SM00523 | |
| Domain | MH1 | 1.63e-04 | 12 | 30 | 2 | PF03165 | |
| Domain | Quinoprot_gluc/sorb_DH | 1.63e-04 | 12 | 30 | 2 | IPR011041 | |
| Domain | SMAD_dom-like | 2.95e-04 | 16 | 30 | 2 | IPR017855 | |
| Domain | - | 2.95e-04 | 16 | 30 | 2 | 2.60.200.10 | |
| Domain | Protein_kinase_ATP_BS | 3.14e-04 | 379 | 30 | 5 | IPR017441 | |
| Domain | Kringle | 3.34e-04 | 17 | 30 | 2 | IPR000001 | |
| Domain | Kringle | 3.34e-04 | 17 | 30 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 3.34e-04 | 17 | 30 | 2 | PS00021 | |
| Domain | Kringle_CS | 3.34e-04 | 17 | 30 | 2 | IPR018056 | |
| Domain | KR | 3.34e-04 | 17 | 30 | 2 | SM00130 | |
| Domain | KRINGLE_2 | 3.34e-04 | 17 | 30 | 2 | PS50070 | |
| Domain | SRCR | 5.14e-04 | 21 | 30 | 2 | PF00530 | |
| Domain | SR | 7.31e-04 | 25 | 30 | 2 | SM00202 | |
| Domain | - | 7.31e-04 | 25 | 30 | 2 | 3.10.250.10 | |
| Domain | PROTEIN_KINASE_ATP | 7.52e-04 | 459 | 30 | 5 | PS00107 | |
| Domain | SRCR_1 | 7.91e-04 | 26 | 30 | 2 | PS00420 | |
| Domain | SRCR-like_dom | 7.91e-04 | 26 | 30 | 2 | IPR017448 | |
| Domain | SRCR_2 | 7.91e-04 | 26 | 30 | 2 | PS50287 | |
| Domain | SRCR | 8.54e-04 | 27 | 30 | 2 | IPR001190 | |
| Domain | Prot_kinase_dom | 1.00e-03 | 489 | 30 | 5 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.04e-03 | 493 | 30 | 5 | PS50011 | |
| Domain | Kringle-like | 1.20e-03 | 32 | 30 | 2 | IPR013806 | |
| Domain | Kinase-like_dom | 1.58e-03 | 542 | 30 | 5 | IPR011009 | |
| Domain | - | 1.78e-03 | 39 | 30 | 2 | 2.120.10.30 | |
| Domain | BTB-kelch_protein | 2.16e-03 | 43 | 30 | 2 | IPR017096 | |
| Domain | Ser/Thr_kinase_AS | 2.43e-03 | 357 | 30 | 4 | IPR008271 | |
| Domain | KRAB | 2.45e-03 | 358 | 30 | 4 | PS50805 | |
| Domain | KRAB | 2.45e-03 | 358 | 30 | 4 | PF01352 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.47e-03 | 46 | 30 | 2 | IPR011042 | |
| Domain | S_TKc | 2.48e-03 | 359 | 30 | 4 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.55e-03 | 362 | 30 | 4 | PS00108 | |
| Domain | KRAB | 2.74e-03 | 369 | 30 | 4 | SM00349 | |
| Domain | KRAB | 2.76e-03 | 370 | 30 | 4 | IPR001909 | |
| Domain | BTB | 2.95e-03 | 180 | 30 | 3 | SM00225 | |
| Domain | Pkinase | 3.07e-03 | 381 | 30 | 4 | PF00069 | |
| Domain | SMAD_FHA_domain | 3.15e-03 | 52 | 30 | 2 | IPR008984 | |
| Domain | BTB/POZ_dom | 3.19e-03 | 185 | 30 | 3 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 3.39e-03 | 189 | 30 | 3 | IPR011333 | |
| Domain | Kelch-typ_b-propeller | 3.51e-03 | 55 | 30 | 2 | IPR015915 | |
| Domain | Kelch | 3.90e-03 | 58 | 30 | 2 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 4.03e-03 | 59 | 30 | 2 | IPR011043 | |
| Domain | BACK | 4.17e-03 | 60 | 30 | 2 | SM00875 | |
| Domain | BACK | 4.30e-03 | 61 | 30 | 2 | PF07707 | |
| Domain | BACK | 4.30e-03 | 61 | 30 | 2 | IPR011705 | |
| Domain | Kelch_1 | 5.63e-03 | 70 | 30 | 2 | PF01344 | |
| Domain | Kelch_1 | 5.63e-03 | 70 | 30 | 2 | IPR006652 | |
| Domain | EGF | 6.21e-03 | 235 | 30 | 3 | SM00181 | |
| Domain | EGF-like_dom | 7.29e-03 | 249 | 30 | 3 | IPR000742 | |
| Domain | EGF_1 | 7.78e-03 | 255 | 30 | 3 | PS00022 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 2.76e-06 | 59 | 24 | 4 | M46460 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | CDK8 ZNF195 ZNF479 ZNF716 ZNF586 CDK1 ABL1 RARA RARB SMAD1 NR2E1 | 5.98e-06 | 1387 | 24 | 11 | M734 |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.71e-05 | 30 | 24 | 3 | M207 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.52e-05 | 768 | 24 | 8 | MM14851 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.52e-05 | 38 | 24 | 3 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 3.52e-05 | 38 | 24 | 3 | MM15865 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 4.15e-05 | 6 | 24 | 2 | M48097 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 5.80e-05 | 7 | 24 | 2 | M47845 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 7.13e-05 | 48 | 24 | 3 | MM14987 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 7.73e-05 | 8 | 24 | 2 | M47847 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 9.61e-05 | 53 | 24 | 3 | M8276 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 9.93e-05 | 9 | 24 | 2 | M47844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 9.93e-05 | 9 | 24 | 2 | M47822 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.39e-04 | 60 | 24 | 3 | M40048 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.46e-04 | 161 | 24 | 4 | M27871 | |
| Pathway | PID_ALK2_PATHWAY | 1.51e-04 | 11 | 24 | 2 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 1.51e-04 | 11 | 24 | 2 | M47848 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.91e-04 | 1022 | 24 | 8 | MM15436 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 2.14e-04 | 13 | 24 | 2 | M39378 | |
| Pathway | BIOCARTA_EFP_PATHWAY | 3.29e-04 | 16 | 24 | 2 | M22011 | |
| Pathway | WP_BMP_SIGNALING_PATHWAY_IN_EYELID_DEVELOPMENT | 5.18e-04 | 20 | 24 | 2 | MM15907 | |
| Pathway | WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT | 5.18e-04 | 20 | 24 | 2 | M39624 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 5.18e-04 | 20 | 24 | 2 | M47843 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 7.49e-04 | 24 | 24 | 2 | M11420 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 7.49e-04 | 24 | 24 | 2 | MM1373 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 7.87e-04 | 108 | 24 | 3 | M48078 | |
| Pathway | WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE | 8.14e-04 | 25 | 24 | 2 | M39665 | |
| Pathway | REACTOME_ADIPOGENESIS | 8.30e-04 | 110 | 24 | 3 | M48259 | |
| Pathway | PID_RXR_VDR_PATHWAY | 8.81e-04 | 26 | 24 | 2 | M162 | |
| Pathway | PID_ALK1_PATHWAY | 8.81e-04 | 26 | 24 | 2 | M185 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.02e-03 | 118 | 24 | 3 | MM15588 | |
| Pathway | BIOCARTA_G1_PATHWAY | 1.02e-03 | 28 | 24 | 2 | M648 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 1.04e-03 | 119 | 24 | 3 | M27785 | |
| Pathway | BIOCARTA_G1_PATHWAY | 1.10e-03 | 29 | 24 | 2 | MM1364 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 1.17e-03 | 30 | 24 | 2 | MM15866 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.25e-03 | 31 | 24 | 2 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 1.25e-03 | 31 | 24 | 2 | MM14789 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 1.25e-03 | 31 | 24 | 2 | M27805 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.42e-03 | 33 | 24 | 2 | MM1448 | |
| Pathway | WP_CANCER_PATHWAYS | 1.42e-03 | 507 | 24 | 5 | M48302 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 1.51e-03 | 34 | 24 | 2 | M16393 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 1.60e-03 | 35 | 24 | 2 | M39488 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 1.78e-03 | 37 | 24 | 2 | M17400 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.78e-03 | 37 | 24 | 2 | M39506 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.84e-03 | 1432 | 24 | 8 | M509 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.05e-03 | 325 | 24 | 4 | M12868 | |
| Pathway | WP_ATM_SIGNALING | 2.08e-03 | 40 | 24 | 2 | M39433 | |
| Pathway | PID_BMP_PATHWAY | 2.29e-03 | 42 | 24 | 2 | M181 | |
| Pathway | WP_VITAMIN_A_AND_CAROTENOID_METABOLISM | 2.40e-03 | 43 | 24 | 2 | M39554 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 2.40e-03 | 43 | 24 | 2 | M27443 | |
| Pathway | WP_RETINOL_METABOLISM | 2.52e-03 | 44 | 24 | 2 | MM15851 | |
| Pathway | WP_MICROTUBULE_CYTOSKELETON_REGULATION | 2.99e-03 | 48 | 24 | 2 | M39566 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 3.11e-03 | 49 | 24 | 2 | MM15186 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 3.24e-03 | 50 | 24 | 2 | MM15817 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 3.63e-03 | 53 | 24 | 2 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 3.90e-03 | 55 | 24 | 2 | M39351 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.48e-03 | 59 | 24 | 2 | M39886 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 4.57e-03 | 200 | 24 | 3 | M48048 | |
| Pathway | WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME | 4.78e-03 | 61 | 24 | 2 | M48077 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2 | 4.94e-03 | 62 | 24 | 2 | MM15521 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 5.58e-03 | 66 | 24 | 2 | MM15925 | |
| Pubmed | 1.13e-09 | 55 | 30 | 5 | 34292881 | ||
| Pubmed | PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. | 9.51e-08 | 11 | 30 | 3 | 15808511 | |
| Pubmed | BMPs are direct triggers of interdigital programmed cell death. | 1.27e-07 | 12 | 30 | 3 | 26826495 | |
| Pubmed | Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. | 1.65e-07 | 13 | 30 | 3 | 19914168 | |
| Pubmed | 3.22e-07 | 16 | 30 | 3 | 23153495 | ||
| Pubmed | 4.68e-07 | 18 | 30 | 3 | 33308444 | ||
| Pubmed | Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation. | 7.19e-07 | 2 | 30 | 2 | 29921692 | |
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 7.19e-07 | 2 | 30 | 2 | 26416749 | |
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 7.19e-07 | 2 | 30 | 2 | 28855340 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 18446813 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 35181333 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21723296 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 7.19e-07 | 2 | 30 | 2 | 30585107 | |
| Pubmed | Regulation of the levels of Smad1 and Smad5 in MC3T3-E1 cells by Icariine in vitro. | 7.19e-07 | 2 | 30 | 2 | 24297369 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26711875 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 1330302 | ||
| Pubmed | The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. | 7.19e-07 | 2 | 30 | 2 | 11451566 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27678455 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 9168777 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31044597 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 36006697 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 37378433 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 1334013 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24833708 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15159591 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 2183353 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32560467 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30601638 | ||
| Pubmed | BMP-SMAD1/5 Signaling Regulates Retinal Vascular Development. | 7.19e-07 | 2 | 30 | 2 | 32210087 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 7644503 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 27306217 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23387849 | ||
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 7.19e-07 | 2 | 30 | 2 | 20408451 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12009305 | ||
| Pubmed | Identification of target genes for the CDK subunits of the Mediator complex. | 7.19e-07 | 2 | 30 | 2 | 22117896 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 8799132 | ||
| Pubmed | 8.82e-07 | 22 | 30 | 3 | 38794925 | ||
| Pubmed | 1.87e-06 | 28 | 30 | 3 | 20346939 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 10652350 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 7607068 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 7607067 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 11172439 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 8383767 | ||
| Pubmed | Non-canonical cyclic AMP SMAD1/5/8 signalling in human granulosa cells. | 2.16e-06 | 3 | 30 | 2 | 30953749 | |
| Pubmed | Regulation of BMP4/Dpp retrotranslocation and signaling by deglycosylation. | 2.16e-06 | 3 | 30 | 2 | 32720893 | |
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 2.16e-06 | 3 | 30 | 2 | 1655807 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23821550 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 29376829 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26002960 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 17252005 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 8626453 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 21381028 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 8388780 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 9659935 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20371744 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 7910825 | ||
| Pubmed | Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo. | 2.16e-06 | 3 | 30 | 2 | 10842077 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 11245412 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23969901 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 10100049 | ||
| Pubmed | BMP signaling initiates a neural crest differentiation program in embryonic rat CNS stem cells. | 2.16e-06 | 3 | 30 | 2 | 15246821 | |
| Pubmed | Differential activation of the murine laminin B1 gene promoter by RAR alpha, ROR alpha, and AP-1. | 2.16e-06 | 3 | 30 | 2 | 8645318 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 9699718 | ||
| Pubmed | Mammalian hexokinase 1: evolutionary conservation and structure to function analysis. | 2.16e-06 | 3 | 30 | 2 | 1783373 | |
| Pubmed | Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. | 2.16e-06 | 3 | 30 | 2 | 1283441 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 22964636 | ||
| Pubmed | Abi enhances Abl-mediated CDC2 phosphorylation and inactivation. | 2.16e-06 | 3 | 30 | 2 | 15591787 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 36446525 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 25505291 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23918166 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24023003 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15528208 | ||
| Pubmed | Association of retinoic acid receptor genes with meningomyelocele. | 2.16e-06 | 3 | 30 | 2 | 21254357 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27848974 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 20522807 | ||
| Pubmed | Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. | 2.16e-06 | 3 | 30 | 2 | 1655630 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 9852056 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 31127639 | ||
| Pubmed | Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. | 2.16e-06 | 3 | 30 | 2 | 15255287 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 22897816 | ||
| Pubmed | Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. | 2.16e-06 | 3 | 30 | 2 | 17244680 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19096363 | ||
| Pubmed | The molecular and genetic dissection of the retinoid signalling pathway. | 2.16e-06 | 3 | 30 | 2 | 8276261 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 33463047 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 21945631 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 14711801 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 22670624 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 15831518 | ||
| Pubmed | Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus. | 2.16e-06 | 3 | 30 | 2 | 8136307 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 24357724 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 30367512 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 8027572 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 2544807 | ||
| Pubmed | [Genetic expression and morphogenesis of the skin in vertebrates]. | 2.16e-06 | 3 | 30 | 2 | 8099268 | |
| Pubmed | Regulation of retinoic acid receptor alpha by protein kinase C in B16 mouse melanoma cells. | 2.16e-06 | 3 | 30 | 2 | 12000751 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 25165122 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 12649288 | ||
| Pubmed | Specificity of retinoid receptor gene expression in mouse cervical epithelia. | 2.16e-06 | 3 | 30 | 2 | 8156902 | |
| Pubmed | Characterization of retinoic acid receptor-deficient keratinocytes. | 2.16e-06 | 3 | 30 | 2 | 10748128 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 25880873 | ||
| Interaction | MED6 interactions | 3.69e-07 | 101 | 30 | 5 | int:MED6 | |
| Interaction | RARB interactions | 6.23e-07 | 46 | 30 | 4 | int:RARB | |
| Interaction | MED25 interactions | 1.06e-05 | 93 | 30 | 4 | int:MED25 | |
| Interaction | CDK8 interactions | 1.77e-05 | 222 | 30 | 5 | int:CDK8 | |
| Interaction | MED24 interactions | 3.74e-05 | 128 | 30 | 4 | int:MED24 | |
| Interaction | GDF6 interactions | 4.48e-05 | 7 | 30 | 2 | int:GDF6 | |
| Interaction | ERCC3 interactions | 1.26e-04 | 175 | 30 | 4 | int:ERCC3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p11 | 2.57e-05 | 87 | 30 | 3 | chr7p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q26 | 6.00e-04 | 55 | 30 | 2 | chr4q26 | |
| Cytoband | 7p11.2 | 6.90e-04 | 59 | 30 | 2 | 7p11.2 | |
| Cytoband | 6q21 | 1.81e-03 | 96 | 30 | 2 | 6q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 2.86e-03 | 121 | 30 | 2 | chr6q21 | |
| GeneFamily | Cyclin dependent kinases | 4.59e-06 | 26 | 23 | 3 | 496 | |
| GeneFamily | Nuclear hormone receptors | 3.19e-05 | 49 | 23 | 3 | 71 | |
| GeneFamily | SMAD family | 4.31e-05 | 8 | 23 | 2 | 750 | |
| GeneFamily | Cyclins|Mediator complex | 7.98e-04 | 33 | 23 | 2 | 1061 | |
| GeneFamily | Kelch like|BTB domain containing | 1.29e-03 | 42 | 23 | 2 | 617 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.20e-02 | 718 | 23 | 4 | 28 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.25e-02 | 134 | 23 | 2 | 861 | |
| Coexpression | KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP | 9.77e-06 | 118 | 30 | 4 | M12313 | |
| Coexpression | KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP | 1.43e-05 | 130 | 30 | 4 | M13537 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 2.32e-05 | 305 | 30 | 5 | M19875 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.12e-06 | 151 | 30 | 4 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.43e-06 | 188 | 30 | 4 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.12e-06 | 198 | 30 | 4 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.31e-05 | 121 | 30 | 3 | 2ae870f822488799cd0ad85e7f72af64e33a867f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.89e-05 | 134 | 30 | 3 | 657ad905b40ec3f82acdef824431b8276d291ef7 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.08e-04 | 138 | 30 | 3 | 05de2cef97c0912fb23f138dd45348f565a14d74 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-04 | 140 | 30 | 3 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-04 | 146 | 30 | 3 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.27e-04 | 146 | 30 | 3 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-04 | 157 | 30 | 3 | ffb8dd381e6b9adc5283fb49586e8bd63773c8d6 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Batf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.58e-04 | 157 | 30 | 3 | 921805932f7974d37aed547861d555b07f30aba6 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-04 | 157 | 30 | 3 | c488ab1d6c6c7e5c2f4426805d1366b44711a031 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.64e-04 | 159 | 30 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, Lineage and Cell Type | 1.64e-04 | 159 | 30 | 3 | f6ad73b6a3681471efbd4fafd9eb631764c53500 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.70e-04 | 161 | 30 | 3 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-04 | 163 | 30 | 3 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 168 | 30 | 3 | d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 169 | 30 | 3 | d2def7229fe9d6b0c70cfed349ede491c8c137a0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 170 | 30 | 3 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.00e-04 | 170 | 30 | 3 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-04 | 170 | 30 | 3 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 173 | 30 | 3 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.10e-04 | 173 | 30 | 3 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 174 | 30 | 3 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 174 | 30 | 3 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 175 | 30 | 3 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 176 | 30 | 3 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-04 | 178 | 30 | 3 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 179 | 30 | 3 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-04 | 180 | 30 | 3 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-04 | 180 | 30 | 3 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 2.40e-04 | 181 | 30 | 3 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 2.44e-04 | 182 | 30 | 3 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-04 | 182 | 30 | 3 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | B_cell_maturation-immature_B_cell|World / Lineage and Cell class | 2.44e-04 | 182 | 30 | 3 | 2c7c51ebc4125d8a33454ffee0b143579ce5e451 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-04 | 182 | 30 | 3 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | facs-Heart-RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 182 | 30 | 3 | 8292e8e8474c930ffb88cbab4f6ebdb6f58db645 | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 2.60e-04 | 186 | 30 | 3 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.60e-04 | 186 | 30 | 3 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 30 | 3 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 30 | 3 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-04 | 186 | 30 | 3 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-04 | 187 | 30 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | B_cell_maturation-immature_B_cell|B_cell_maturation / Lineage and Cell class | 2.64e-04 | 187 | 30 | 3 | 9afbb21654c8eb6f9c6a7cbd0664d890282ddceb | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-04 | 188 | 30 | 3 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 188 | 30 | 3 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-04 | 188 | 30 | 3 | e7681efb4d2de7f1d8a89552fff76a829376bf1b | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 189 | 30 | 3 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.72e-04 | 189 | 30 | 3 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 189 | 30 | 3 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 189 | 30 | 3 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.72e-04 | 189 | 30 | 3 | 620d30bb6211fff6adab0638d0d994f547167a29 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.77e-04 | 190 | 30 | 3 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-04 | 190 | 30 | 3 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-04 | 190 | 30 | 3 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-04 | 190 | 30 | 3 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-04 | 190 | 30 | 3 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-04 | 191 | 30 | 3 | ddbc5f97f2aef19be4ad93db4139876c939b848e | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-pre-B-I_cell|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.81e-04 | 191 | 30 | 3 | 146edd214aac49f9b910bb982e3d77a052c8b316 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-04 | 192 | 30 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-04 | 192 | 30 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.90e-04 | 193 | 30 | 3 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-04 | 194 | 30 | 3 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 194 | 30 | 3 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-04 | 194 | 30 | 3 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 3.03e-04 | 196 | 30 | 3 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 196 | 30 | 3 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-04 | 196 | 30 | 3 | c373465e34e2dd581247962d59e0477aae877079 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-04 | 196 | 30 | 3 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 196 | 30 | 3 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-04 | 196 | 30 | 3 | 8b5337ccf74de90e8b89a02ac00671af1de2cfff | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-04 | 197 | 30 | 3 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-04 | 197 | 30 | 3 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 197 | 30 | 3 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-04 | 197 | 30 | 3 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | Transverse-T_cell-cycling_gd_T|Transverse / Region, Cell class and subclass | 3.12e-04 | 198 | 30 | 3 | 5131b0b7d6c4dd8872cef9f2e233f59f751b4690 | |
| ToppCell | Transverse-(1)_T_cell-(18)_cycling_gd_T|Transverse / shred on region, Cell_type, and subtype | 3.12e-04 | 198 | 30 | 3 | 396dddf7ebad41c3a91329b6a280623c0dfdcd2f | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.17e-04 | 199 | 30 | 3 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | cellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.17e-04 | 199 | 30 | 3 | 20e62a7029fa0d214244cdf2a481fc5d78290438 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-04 | 199 | 30 | 3 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.17e-04 | 199 | 30 | 3 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | distal-mesenchymal-Pericyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.17e-04 | 199 | 30 | 3 | e72ac7a00405cde06293d7adac7dc40eb0cf87ba | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.17e-04 | 199 | 30 | 3 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Smooth_Muscle_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.17e-04 | 199 | 30 | 3 | 31c781a1787e5140fb3f611823cbab4d13d02dfa | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.17e-04 | 199 | 30 | 3 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.17e-04 | 199 | 30 | 3 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | medial-mesenchymal-Pericyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-04 | 200 | 30 | 3 | bbda454260016be92b539e220ecf7bcbbc6139e4 | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-04 | 200 | 30 | 3 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-FILIP1L|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | f6af5ef02625aaae21e885e1ebd195e34731e53a | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.22e-04 | 200 | 30 | 3 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.22e-04 | 200 | 30 | 3 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.22e-04 | 200 | 30 | 3 | 43b76e382b38b9856c07557a75e5b1ce0cee1d9e | |
| Drug | Ro 8-8717 | 1.68e-06 | 2 | 30 | 2 | CID006438148 | |
| Drug | Tamibarotene | 1.68e-06 | 2 | 30 | 2 | DB04942 | |
| Drug | AGN 193109 | 9.05e-06 | 31 | 30 | 3 | CID000177238 | |
| Drug | SRI 5898-21 | 1.01e-05 | 4 | 30 | 2 | CID006439757 | |
| Drug | Tazarotene | 1.01e-05 | 4 | 30 | 2 | DB00799 | |
| Drug | Cd2366 | 1.67e-05 | 5 | 30 | 2 | CID006443796 | |
| Drug | Alitretinoin | 2.51e-05 | 6 | 30 | 2 | DB00523 | |
| Drug | Adapalene | 2.51e-05 | 6 | 30 | 2 | DB00210 | |
| Drug | Etretinate | 2.51e-05 | 6 | 30 | 2 | DB00926 | |
| Drug | Acitretin | 3.51e-05 | 7 | 30 | 2 | DB00459 | |
| Drug | 5-methoxypsoralen | 3.51e-05 | 7 | 30 | 2 | ctd:C022909 | |
| Drug | HX 600 | 4.68e-05 | 8 | 30 | 2 | ctd:C104181 | |
| Drug | 2-naphthoic acid | 4.68e-05 | 8 | 30 | 2 | CID000007123 | |
| Drug | 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid | 4.68e-05 | 8 | 30 | 2 | ctd:C064545 | |
| Drug | Adapalene | 4.68e-05 | 8 | 30 | 2 | ctd:D000068816 | |
| Drug | TTNN | 4.68e-05 | 8 | 30 | 2 | CID000135754 | |
| Drug | LDN 193189 | 4.68e-05 | 8 | 30 | 2 | ctd:C554430 | |
| Drug | 4-((4-(4-ethylphenyl)-2,2-dimethyl-(2H)-thiochromen-6-yl)ethynyl)benzoic acid | 4.68e-05 | 8 | 30 | 2 | ctd:C121616 | |
| Drug | retinyl methyl ether | 6.01e-05 | 9 | 30 | 2 | CID006436634 | |
| Drug | tetraarsenic tetrasulfide | 6.71e-05 | 60 | 30 | 3 | ctd:C534735 | |
| Drug | HX 630 | 7.50e-05 | 10 | 30 | 2 | ctd:C422175 | |
| Drug | Flavopiridol | 7.50e-05 | 10 | 30 | 2 | DB03496 | |
| Drug | CEPC | 7.50e-05 | 10 | 30 | 2 | CID000011483 | |
| Drug | UVI 3003 | 9.16e-05 | 11 | 30 | 2 | ctd:C525131 | |
| Drug | NSC105327 | 1.06e-04 | 70 | 30 | 3 | CID005318433 | |
| Drug | 4-hydroxyretinoic acid | 1.10e-04 | 12 | 30 | 2 | ctd:C019429 | |
| Drug | Puromycin Aminonucleoside | 1.13e-04 | 192 | 30 | 4 | ctd:D011692 | |
| Drug | Vinpocetine [42971-09-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 7213_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.25e-04 | 197 | 30 | 4 | 1048_UP | |
| Drug | iloprost; Down 200; 1uM; MCF7; HG-U133A | 1.25e-04 | 197 | 30 | 4 | 427_DN | |
| Drug | Ro 13-6298 | 1.30e-04 | 13 | 30 | 2 | CID006437076 | |
| Drug | Cd2665 | 1.30e-04 | 13 | 30 | 2 | CID000216241 | |
| Drug | Nomifensine maleate [32795-47-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 2224_UP | |
| Drug | Phenytoin | 1.36e-04 | 385 | 30 | 5 | ctd:D010672 | |
| Drug | Griseofulvin | 1.41e-04 | 77 | 30 | 3 | ctd:D006118 | |
| Drug | 3-deazacytidine | 1.48e-04 | 206 | 30 | 4 | CID000001652 | |
| Drug | AC1L1DMQ | 1.51e-04 | 14 | 30 | 2 | CID000002418 | |
| Drug | TAC 101 | 1.99e-04 | 16 | 30 | 2 | ctd:C112689 | |
| Drug | PD166326 | 1.99e-04 | 16 | 30 | 2 | CID000447700 | |
| Drug | protoporphyrin IX dimethyl ester | 2.25e-04 | 17 | 30 | 2 | CID000194637 | |
| Drug | U0126 | 2.27e-04 | 430 | 30 | 5 | CID000005637 | |
| Drug | bexarotene | 2.44e-04 | 437 | 30 | 5 | ctd:C095105 | |
| Drug | SR11237 | 2.53e-04 | 18 | 30 | 2 | CID000127019 | |
| Drug | HX600 | 2.53e-04 | 18 | 30 | 2 | CID000128016 | |
| Drug | 3,4-didehydroretinoic acid | 2.53e-04 | 18 | 30 | 2 | CID000447276 | |
| Drug | 4-(1H-imidazol-1-yl)retinoic acid | 2.53e-04 | 18 | 30 | 2 | ctd:C496751 | |
| Drug | STO 609 | 2.83e-04 | 19 | 30 | 2 | ctd:C458525 | |
| Drug | Mitoxantrone | 2.97e-04 | 247 | 30 | 4 | ctd:D008942 | |
| Drug | imperatorin | 3.81e-04 | 22 | 30 | 2 | ctd:C031534 | |
| Drug | adapalene | 3.81e-04 | 22 | 30 | 2 | CID000060164 | |
| Drug | Ro 15-0778 | 4.17e-04 | 23 | 30 | 2 | CID006436116 | |
| Drug | AC1L32JQ | 4.17e-04 | 23 | 30 | 2 | CID000133319 | |
| Drug | 4-hydroxyretinoic acid | 4.94e-04 | 25 | 30 | 2 | CID006438629 | |
| Drug | AN-22 | 5.77e-04 | 27 | 30 | 2 | CID000055769 | |
| Drug | AC1L2X6Z | 5.77e-04 | 27 | 30 | 2 | CID000130325 | |
| Drug | olomoucine | 6.90e-04 | 132 | 30 | 3 | CID000004592 | |
| Drug | Vincristine | 7.09e-04 | 1182 | 30 | 7 | ctd:D014750 | |
| Drug | AGN 193109 | 7.14e-04 | 30 | 30 | 2 | ctd:C096920 | |
| Drug | Ro 41-5253 | 7.14e-04 | 30 | 30 | 2 | ctd:C084904 | |
| Drug | gentamicin sulfate | 7.62e-04 | 31 | 30 | 2 | CID000072396 | |
| Drug | BAME | 8.12e-04 | 32 | 30 | 2 | CID000150869 | |
| Drug | rhodioloside | 8.12e-04 | 32 | 30 | 2 | ctd:C009172 | |
| Drug | CD367 | 8.64e-04 | 33 | 30 | 2 | CID000119342 | |
| Drug | Retinoids | 9.17e-04 | 34 | 30 | 2 | ctd:D012176 | |
| Drug | methyl ethyl ketone | 9.36e-04 | 587 | 30 | 5 | CID000006569 | |
| Drug | imidacloprid | 9.72e-04 | 35 | 30 | 2 | ctd:C082359 | |
| Drug | Pesticides | 9.99e-04 | 150 | 30 | 3 | ctd:D010575 | |
| Drug | trans-retinol acetate | 1.03e-03 | 36 | 30 | 2 | CID000005057 | |
| Drug | monocrotaline pyrrole | 1.03e-03 | 36 | 30 | 2 | CID000104764 | |
| Drug | 5-amidinobenzimidazole | 1.08e-03 | 154 | 30 | 3 | CID000001800 | |
| Drug | Ro 41-5253 | 1.09e-03 | 37 | 30 | 2 | CID005312120 | |
| Drug | Cytochalasin D | 1.21e-03 | 39 | 30 | 2 | ctd:D015638 | |
| Drug | purvalanol | 1.27e-03 | 40 | 30 | 2 | CID000448991 | |
| Drug | tazarotene | 1.27e-03 | 40 | 30 | 2 | CID000005381 | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 8.68e-07 | 2 | 28 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 5.20e-06 | 4 | 28 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 5.20e-06 | 4 | 28 | 2 | C0751925 | |
| Disease | Lesion of Sciatic Nerve | 5.20e-06 | 4 | 28 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 5.20e-06 | 4 | 28 | 2 | C0242013 | |
| Disease | Sciatic Neuropathy | 5.20e-06 | 4 | 28 | 2 | C0149940 | |
| Disease | Congenital ocular coloboma (disorder) | 3.11e-05 | 9 | 28 | 2 | C0009363 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 6.73e-05 | 13 | 28 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 1.80e-04 | 21 | 28 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Adenocarcinoma | 1.81e-04 | 116 | 28 | 3 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 1.81e-04 | 116 | 28 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.81e-04 | 116 | 28 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.81e-04 | 116 | 28 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.81e-04 | 116 | 28 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.81e-04 | 116 | 28 | 3 | C0205641 | |
| Disease | Endometrioma | 4.72e-04 | 161 | 28 | 3 | C0269102 | |
| Disease | Endometriosis | 4.72e-04 | 161 | 28 | 3 | C0014175 | |
| Disease | Schizophrenia | 1.32e-03 | 883 | 28 | 5 | C0036341 | |
| Disease | Withdrawal Symptoms | 1.39e-03 | 58 | 28 | 2 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.39e-03 | 58 | 28 | 2 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.39e-03 | 58 | 28 | 2 | C0038587 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.85e-03 | 301 | 28 | 3 | DOID:684 (is_marker_for) | |
| Disease | hormone measurement | 2.88e-03 | 84 | 28 | 2 | EFO_0004730 | |
| Disease | amino acid measurement | 3.65e-03 | 678 | 28 | 4 | EFO_0005134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KGGEHCYYHGSIRGV | 191 | O75077 | |
| EYEGCKVGRGTYGHV | 21 | Q9BWU1 | |
| DCHGGISGTIYEYGA | 31 | P22352 | |
| DKYCVEYGVGVIGFH | 151 | O95803 | |
| SGYHYGVSACEGCKG | 96 | P10276 | |
| SGYHYGVSACEGCKG | 96 | P10826 | |
| GGKGSHEGRLEVYYR | 391 | P56730 | |
| GDYTCASDGGIRKGY | 581 | Q96PR1 | |
| VGKSVTGGYVYRGCE | 471 | Q96JK4 | |
| RKGYGICHGTAGNGY | 361 | Q9NS86 | |
| GYYGDPIIGSGDHCR | 901 | P07942 | |
| GKIYISGGVHNGEYV | 471 | Q9P2G3 | |
| IGGHCGYRGSCTYDK | 421 | Q8NBE8 | |
| HKLGGGQYGEVYEGV | 246 | P00519 | |
| AYGHAVGKSVTGGYV | 491 | Q6UWX4 | |
| VGKSVTGGYVYRGCE | 496 | Q6UWX4 | |
| EYEGCKVGRGTYGHV | 21 | P49336 | |
| QHCGGELGDYTGYIE | 796 | Q8IWY4 | |
| DRSSGKHYGVYACDG | 21 | Q9Y466 | |
| GDTYEGSYEFGKRHG | 41 | Q8WYR4 | |
| SGCTVEIKGGAHDYY | 301 | Q8IYS1 | |
| GKGVHLYYVGGEVYA | 331 | Q99717 | |
| GKGVHLYYVGGEVYA | 331 | Q15797 | |
| GEGTYGVVYKGRHKT | 11 | P06493 | |
| YKDQGGHSGERPYEC | 76 | Q9NXT0 | |
| DEYGYEVGKAIGHGS | 21 | Q6SA08 | |
| EVGKAIGHGSYGSVY | 26 | Q6SA08 | |
| SVGECEVHKGGYNYV | 131 | A6NP11 | |
| SVGEYEVHKGGYSEV | 131 | Q96JC4 | |
| GEGCDRDGKYGFYTH | 591 | P00734 | |
| RYEGHKVEGYSVGCE | 466 | Q64LD2 | |
| YAGGEHYRCEEFGKV | 321 | O14628 |